ArticleMolecular oncology2019

Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.

Takayuki Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.